Abstract
The malignant glioma, grades III and IV, is a cancer of rare biological consistency which until the advent of recent therapeutic advances had a median survival time of 6 months and killed 90% in 18 months [1]. There are 385,000 deaths from cancer each year in the USA of which 50,000 (13%) are associated with central nervous system involvement. It is estimated that of the 50,000 deaths, 8,500 (17%) are caused by primary brain tumors and 5,000 of these can be attributed to the malignant glioma or glioblastoma. The number of deaths from malignant gliomas is about half those reported from leukemia but are, in fact, more common than those from Hodgkin’s disease [2]. At the New York University Medical Center in the last 1,000 surgically verified primary supratentorial tumors in adults, 500 represent tumors of glial origin. Eighty percent of glial tumors were in the malignant glioma and glioblastoma class, 10% in the grade I, II and mixed glial groups and 10% represented oligodendrogliomas, ependymomas and other less common forms of primary tumors of neural origin.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Walker MD, Alexander E, Hunt W et al:Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J Neurosurg 49:333–343, 1978.
Shapiro W:Chemotherapy of nervous system neoplasms in primary intracranial neoplasms. In:Scher J, Ford D (eds). New York, Spectrum Press, 1979.
Russell DS, Rubinstein LJ:Pathology of the nervous system, 4th edition. Baltimore, The Williams and Wilkins Company, 1977, pp 147–282.
Jellinger K:Glioblastoma multiforme:morphology and biology. Acta Neurochirg 42:5–32, 1978.
Ambrose J, Gooding HR, Richardson AE:In:Brain 98:569–582, 1975.
Flamm E, Ransohoff J, Wuchinich D et al:Preliminary experience with ultrasonic aspiration in neurosurgery. Neurosurg 2:240–245, 1978.
Cooper PR, Rovit RL, Ransohoff J:Hemicraniectomy in the treatment of acute subdural hematoma:a reappraisal. Surg Neorol 5:25–30, 1976.
Ransohoff J, Lieberman A:Surgical therapy of primary malignant brain tumors. Clin Neurosurg 25:403–411, 1978.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Martinus Nijhoff Publishers, Boston/The Hague/Dordrecht/Lancaster
About this chapter
Cite this chapter
Ransohoff, J. (1983). The Role of Intracranial Surgery for the Treatment of Malignant Gliomas. In: Walker, M.D. (eds) Oncology of the Nervous System. Cancer Treatment and Research, vol 12. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3858-1_4
Download citation
DOI: https://doi.org/10.1007/978-1-4613-3858-1_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-3860-4
Online ISBN: 978-1-4613-3858-1
eBook Packages: Springer Book Archive